Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Necrobiosis Lipoidica | 1 | 2019 | 11 | 0.740 |
Why?
|
Erythema Multiforme | 1 | 2019 | 37 | 0.710 |
Why?
|
Scalp Dermatoses | 1 | 2019 | 52 | 0.690 |
Why?
|
Skin Ulcer | 1 | 2019 | 125 | 0.650 |
Why?
|
Herpesvirus 3, Human | 1 | 2019 | 219 | 0.640 |
Why?
|
Herpes Zoster | 1 | 2019 | 288 | 0.570 |
Why?
|
Antigens, Viral | 1 | 2019 | 1159 | 0.500 |
Why?
|
Sarcoidosis | 1 | 2019 | 524 | 0.480 |
Why?
|
Lung Diseases | 1 | 2019 | 1904 | 0.340 |
Why?
|
Skin | 2 | 2022 | 4291 | 0.290 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5444 | 0.200 |
Why?
|
Necrobiotic Xanthogranuloma | 1 | 2020 | 11 | 0.200 |
Why?
|
Paraproteinemias | 1 | 2020 | 247 | 0.160 |
Why?
|
Surgery, Plastic | 1 | 2022 | 560 | 0.150 |
Why?
|
Obesity | 1 | 2019 | 12268 | 0.150 |
Why?
|
Thyroid Diseases | 1 | 2019 | 384 | 0.140 |
Why?
|
Pleural Effusion, Malignant | 1 | 2015 | 100 | 0.130 |
Why?
|
Rare Diseases | 1 | 2019 | 529 | 0.120 |
Why?
|
Sex Distribution | 1 | 2019 | 2370 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1673 | 0.120 |
Why?
|
Dermatology | 1 | 2022 | 846 | 0.120 |
Why?
|
Age Distribution | 1 | 2019 | 2942 | 0.110 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 419 | 0.110 |
Why?
|
Catheter-Related Infections | 1 | 2015 | 240 | 0.110 |
Why?
|
Radiation Oncology | 1 | 2017 | 510 | 0.110 |
Why?
|
Dyslipidemias | 1 | 2019 | 848 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 628 | 0.090 |
Why?
|
Radiotherapy | 1 | 2017 | 1613 | 0.090 |
Why?
|
Biopsy | 1 | 2019 | 6732 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8888 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11664 | 0.070 |
Why?
|
Comorbidity | 1 | 2019 | 10429 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5319 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13215 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 23385 | 0.050 |
Why?
|
Esthetics | 1 | 2022 | 303 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15900 | 0.050 |
Why?
|
Hypertension | 1 | 2019 | 8270 | 0.050 |
Why?
|
Female | 6 | 2020 | 377052 | 0.040 |
Why?
|
Aged | 3 | 2020 | 162392 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 28991 | 0.040 |
Why?
|
Middle Aged | 4 | 2020 | 214639 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23482 | 0.040 |
Why?
|
Humans | 8 | 2022 | 715594 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 56140 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2355 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2022 | 1391 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 11736 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 72448 | 0.030 |
Why?
|
Adolescent | 2 | 2019 | 85064 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58293 | 0.030 |
Why?
|
Risk Factors | 1 | 2019 | 70931 | 0.030 |
Why?
|
Bacteria | 1 | 2022 | 2113 | 0.030 |
Why?
|
Male | 4 | 2020 | 350143 | 0.020 |
Why?
|
Infection Control | 1 | 2015 | 953 | 0.020 |
Why?
|
Adult | 2 | 2019 | 212237 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2020 | 4966 | 0.010 |
Why?
|
Palliative Care | 1 | 2015 | 3286 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 24776 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40040 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 20761 | 0.010 |
Why?
|
Infant | 1 | 2017 | 34561 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41184 | 0.010 |
Why?
|
Child | 1 | 2017 | 74413 | 0.010 |
Why?
|
United States | 1 | 2015 | 67895 | 0.000 |
Why?
|
Concepts
(66)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_